Which Cancers are Associated with Met Amplification?
Met amplification has been observed in various types of cancers, including lung cancer, gastric cancer, and colorectal cancer. It is particularly common in non-small cell lung cancer (NSCLC) and has been identified as both a primary driver mutation and a mechanism of acquired resistance to EGFR inhibitors.
